相关实验视频
Updated: Sep 15, 2025

05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
357
腹手术后药物的药理动力学变化:一个范围审查
Heeyoung Lee1, Brayden Kameg1, Josua Palmer1
1University of Pittsburgh, School of Nursing, PA.
The journal for nurse practitioners : JNP
|July 15, 2025
概括
腹部外科手术后的患者通常需要更高的抗抑郁剂剂量,因为药物代谢发生变化. 密切监测和剂量调整对于在这个人群中管理精神药物药物至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 临床药房 临床药房
- 胃肠病学 胃肠病学
背景情况:
- 没有确定的指导方针存在于手术后管理心理药物.
- 腹腔外科手术显著影响药物的药理动力学.
- 抗抑郁药物管理需要在减肥手术后仔细考虑.
研究的目的:
- 在减肥手术后审查抗抑郁药的药理学变化.
- 探索这些药理动力学变化的临床影响.
- 为医疗保健提供者提供关于减肥患者心理药物管理的信息.
主要方法:
- 进行了系统的文献搜索.
- 选了245篇文章,其中包括7项相关研究.
- 审查重点关注药物动力学变化和临床影响.
主要成果:
- 在手术后观察到抗抑郁药物生物可用性和新陈代谢的显著变化.
- 许多患者需要增加药物剂量以维持治疗水平.
- 药物水平通常在术后6至12个月内恢复到基线.
结论:
- 在减肥手术后,密切监测患者至关重要.
- 经常需要调整抗抑郁药的配方和剂量.
- 研究结果为管理这种群体中的精神药物药物提供了关键的见解.
相关概念视频
Biopharmaceutics and Pharmacokinetics: Overview
2.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.6K
Pharmacokinetics: Overview
7.2K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
7.2K
Drug Biotransformation: Overview
2.9K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.9K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
302
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
302
Nonlinear Pharmacokinetics: Role of Transporters
100
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
100
Factors Affecting Drug Biotransformation: Biological
244
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
244

